Botox continues to be one of the most sought after procedures. Patients come to Revalla wanting a refreshed and wrinkle free complexion. With the help of Botox, Dr. Hunsicker can reduce the unsightliness of fine facial lines. Proving its popularity, in 2013 alone, 6.3 million Botox injectable treatments were performed. An ever-popular treatment, Botox tends to get a bad rep. Here, we debunk 5 commonly believed myths. Continue reading “Botox: 5 Myths Not To Believe” »
Last month, we talked about the benefits of aging prevention and refining your body’s contours in your thirties. For part two of our series on the best cosmetic procedures and treatments to help you age gracefully, we will be focusing on those fantastic forties. Continue reading “Aging Gracefully, Part II” »
One of the biggest concerns that patients have is how to maintain a youthful appearance throughout life. We all see the celebrities doing it on television and in the movies, making their fifties look more like their thirties and appearing to almost never age. Continue reading “Aging Gracefully, Part I” »
BOOSTING CONFIDENCE WITH COSMETIC SURGERYDenver winters not only mean it’s time for snowy weather, but it also means a time for snuggling up by the fire, drinking Peppermint Mochas, and making plans for huge family feasts. For many of us, it also means wanting to look our best through it all. If you have discovered a few wrinkles around the eyes from all this holiday planning, now is the time to check out what a non-surgical facial treatment can do for you – just in time for all those festivities! Continue reading “WHAT MANY DENVER RESIDENTS ARE DOING OVER THEIR HOLIDAY BREAK” »
Cheaper Isn’t Always BetterThe increasing number of people administering illegal cosmetic procedures has sparked new warnings by the American Society for Aesthetic Plastic Surgery (ASAPS). Continue reading “WHY YOU NEED TO AVOID UNQUALIFIED PERSONNEL FOR YOUR COSMETIC PROCEDURES” »
Juvederm could be FDA Approved for cheek augmentation later this year.A US Food and Drug Administration (FDA) panel has recommended that the agency approve Juvéderm Voluma XC (Allergen) for cheek augmentation. The product would be the first injectable dermal filler permitted in the US for the mid-face. If approval takes place – and the FDA generally follows advisory committee recommendations — it should be available as soon as late 2013. A gel composed of hyaluronic acid suspended in phosphate buffered saline with 0.3 percent Lidocaine, Juvéderm Voluma helps restore deep volume loss and smooths the mid-face, rejuvenating sunken areas around the cheeks, re-creating youthful contour and fullness. The results are instant, natural looking and can last up to 18 months. There’s little if any downtime – most people resume normal activities immediately. Based on the clinical trial data presented, the FDA’s General and Plastic Surgery Devices Panel agreed that the product is effective and safe and the benefits outweigh the risks. The most frequent common treatment site responses (CTRs) reported in the trial were tenderness, swelling, and firmness. FDA reviewers noted that the incidence of CTRs decreased for subjects receiving touch-up and repeat treatments. More than half (52.8 percent) of subjects received the optional retreatment at the end of the extended follow-up period “suggesting these subjects perceived an acceptable benefit/risk profile for [its] continued use,” the reviewers said. An additional consensus was that Juvéderm Voluma XC fills more than cheeks, meeting the needs of what people want in plastic surgery. According to the American Society for Dermatologic Surgery (ASDS), in 2012 nearly 2 million people had soft tissue filler augmentation, representing a 205 percent increase since 2000. Photo by Alaskan Dude on Flickr
Side effects are minimal for soft-tissue fillers, according to recent study.Three injectable soft-tissue fillers designed to reduce facial wrinkles and lines and provide a more youthful, fresher appearance have been deemed to be safe, according to a recent study in JAMA Facial Plastic Surgery. Over a five-year period, researchers reviewed data on 2,089 office-based injections for these so-called liquid facelifts. The study included 1,047 injections of hyaluronic acid (brand names Juvederm, Restylane, Puragen, Captique, Esthélis, Elevess, Hylaform, Perlane and Prevelle), 811 with poly-L-lactic acid (known as Sculptra) and 231 with calcium hydroxylapatite (Radiesse).
Before and After Juvederm®. Photo courtesy of Allergan Inc.
USA Today article states that Botox has grown in popularity consistently since it was first approved by the FDA ten years ago. In just a short time, it has skyrocketed in popularity, becoming one of the most common cosmetic procedures in the world. In those ten years, Botox has grown from a $97 million per year drug treating muscle spasms to a $1.8 billion per year cosmetic industry standby. And the numbers should keep increasing, as the injections have recently been FDA approved for migraines and urinary incontinence, and are in the process of seeking approval for knee joint pain and other bladder issues.